Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04313075 | A Compassionate Use Study of Leronlimab in Breast Cancer | no longer available | — | — | CytoDyn, Inc.INDUSTRY | 0 | Jul 15, 2025 | clinicaltrials |
| NCT03123211 | Expanded Access to Veliparib | no longer available | — | — | AbbVieINDUSTRY | 0 | May 24, 2022 | clinicaltrials |
| NCT05108740 |
| MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer |
| no longer available |
| — |
| — |
| Novartis PharmaceuticalsINDUSTRY |
| 0 |
| Dec 9, 2021 |
| clinicaltrials |
| NCT02985658 | Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer | no longer available | — | — | University of WashingtonOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT03706573 | Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 0 | Jul 19, 2021 | clinicaltrials |
| NCT03554434 | An Expanded Access Program for AM0010 (Pegilodecakin) | no longer available | — | — | Eli Lilly and CompanyINDUSTRY | 0 | Mar 2, 2020 | clinicaltrials |
| NCT01120561 | A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer | no longer available | — | — | Genentech, Inc.INDUSTRY | 1 | Feb 15, 2017 | clinicaltrials |
| NCT01626781 | A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer(PROCAPP) | no longer available | — | — | AIO-Studien-gGmbHOTHER | 1 | Oct 22, 2013 | clinicaltrials |
| NCT01130259 | An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer | no longer available | — | — | SanofiINDUSTRY | 0 | Sep 17, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 15, 2025source: clinicaltrials